12-109793560-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PM5PP3_ModeratePP5_Moderate
The NM_021625.5(TRPV4):c.1625C>A(p.Ser542Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S542C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_021625.5 missense
Scores
Clinical Significance
Conservation
Publications
- metatropic dysplasiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- neuromuscular diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- spondylometaphyseal dysplasia, Kozlowski typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- TRPV4-related bone disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- autosomal dominant brachyolmiaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- Charcot-Marie-Tooth disease axonal type 2CInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- scapuloperoneal spinal muscular atrophy, autosomal dominantInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- familial avascular necrosis of femoral headInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial digital arthropathy-brachydactylyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neuronopathy, distal hereditary motor, autosomal dominant 8Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- parastremmatic dwarfismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRPV4 | NM_021625.5 | c.1625C>A | p.Ser542Tyr | missense_variant | Exon 10 of 16 | ENST00000261740.7 | NP_067638.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TRPV4 | ENST00000261740.7 | c.1625C>A | p.Ser542Tyr | missense_variant | Exon 10 of 16 | 1 | NM_021625.5 | ENSP00000261740.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2C Pathogenic:2
This sequence change replaces serine, which is neutral and polar, with tyrosine, which is neutral and polar, at codon 542 of the TRPV4 protein (p.Ser542Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease and short stature (PMID: 21115951). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 30469). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TRPV4 protein function. For these reasons, this variant has been classified as Pathogenic. -
- -
Neuromuscular disease;C0410528:Skeletal dysplasia Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at